DaVita (NYSE:DVA) Hits New 52-Week High – Here’s Why

DaVita Inc. (NYSE:DVA)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $172.17 and last traded at $172.71, with a volume of 12210 shares traded. The stock had previously closed at $170.28.

Analyst Ratings Changes

Several research analysts have recently commented on DVA shares. Barclays raised their price objective on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial raised their price target on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research report on Monday, October 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, DaVita currently has an average rating of “Hold” and a consensus price target of $161.80.

DaVita Price Performance

The stock’s 50 day moving average is $159.01 and its two-hundred day moving average is $154.48. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The stock has a market capitalization of $14.20 billion, a PE ratio of 18.68, a price-to-earnings-growth ratio of 0.82 and a beta of 0.92.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). The firm had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. DaVita had a net margin of 6.53% and a return on equity of 88.18%. DaVita’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.85 earnings per share. As a group, sell-side analysts forecast that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Public Sector Pension Investment Board purchased a new position in DaVita in the second quarter valued at approximately $235,000. MBB Public Markets I LLC acquired a new position in shares of DaVita in the 2nd quarter valued at $582,000. The Manufacturers Life Insurance Company grew its position in shares of DaVita by 0.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 45,244 shares of the company’s stock valued at $6,269,000 after buying an additional 150 shares during the last quarter. Creative Planning raised its stake in DaVita by 5.0% during the 2nd quarter. Creative Planning now owns 8,297 shares of the company’s stock worth $1,150,000 after acquiring an additional 394 shares in the last quarter. Finally, B. Riley Wealth Advisors Inc. lifted its position in DaVita by 78.9% in the second quarter. B. Riley Wealth Advisors Inc. now owns 4,130 shares of the company’s stock valued at $572,000 after acquiring an additional 1,822 shares during the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.